Search hospitals > Colorado > Boulder
Boulder Community Foothills Hospital
Claim this profileBoulder, Colorado 80303
Global Leader in Cancer
Global Leader in Breast Cancer
Conducts research for Lymphoma
Conducts research for Lung Cancer
Conducts research for Tumors
56 reported clinical trials
1 medical researcher
Summary
Boulder Community Foothills Hospital is a medical facility located in Boulder, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lymphoma, Lung Cancer, Tumors and other specialties. Boulder Community Foothills Hospital is involved with conducting 56 clinical trials across 204 conditions. There are 1 research doctors associated with this hospital, such as Nicholas DiBella.Area of expertise
1Cancer
Global LeaderStage IV
Stage III
Stage I
2Breast Cancer
Global LeaderStage IV
HER2 positive
Stage II
Top PIs
Clinical Trials running at Boulder Community Foothills Hospital
Breast Cancer
Lung Cancer
Non-Small Cell Lung Cancer
Melanoma
Bladder Cancer
Cancer
Cutaneous Melanoma
Gastroesophageal Junction Adenocarcinoma
Gastric Cancer
Esophageal Cancer
Sacituzumab Govitecan
for Brain Metastases from Breast Cancer
This phase II trial studies the effect of sacituzumab govitecan in treating patients with HER2-negative breast cancer that has spread to the brain (brain metastases). Sacituzumab govitecan is a monoclonal antibody, called sacituzumab, linked to a chemotherapy drug, called govitecan. Sacituzumab is a form of targeted therapy because it attaches to specific molecules on the surface of cancer cells, known as Trop-2 receptors, and delivers govitecan to kill them. Giving sacituzumab govitecan may shrink the cancer in the brain and/or extend the time until the cancer gets worse.
Recruiting1 award Phase 212 criteria
Mobile Health
for Breast Cancer
This clinical trial compares the use of the connected customized treatment platform (CONCURxP), consisting of using a medication monitoring device called WiseBag along with text message reminders for missed or extra medication events, to enhanced usual care (EUC), where patients only use the WiseBag, to monitor medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor. To ensure CDK4/6 inhibitors achieve their full clinical benefit, patients need to take them as prescribed, following a complex treatment schedule. Forgetfulness was the most common reason reported for medication non adherence. Using the WiseBag along with CONCURxP or enhanced usual care may improve medication adherence in patients with metastatic breast cancer who are taking a CKD4/6 inhibitor.
Recruiting1 award N/A10 criteria
Cognitive Training
for Breast Cancer Survivors
This Phase III trial will examine the efficacy of computerized cognitive training methods on perceived cognitive impairment in breast cancer survivors.
Recruiting1 award N/A5 criteria
Similar Hospitals nearby
Frequently asked questions
What kind of research happens at Boulder Community Foothills Hospital?
Boulder Community Foothills Hospital is a medical facility located in Boulder, Colorado. This center is recognized for care of Cancer, Breast Cancer, Lymphoma, Lung Cancer, Tumors and other specialties. Boulder Community Foothills Hospital is involved with conducting 56 clinical trials across 204 conditions. There are 1 research doctors associated with this hospital, such as Nicholas DiBella.